Cross-Regional Pitch & Match session

12 Jun 2025 | Park Inn by Radisson Leuven -

LivingMed Biotech

Drug discovery companies

www.livingmedbiotech.comLiege, Belgium
2 profile visits

About

LMB wants to lead the fight against viral threads for animals and humans through scalable, game-changing vaccine solutions, securing global health and transforming food supply chains.

Our mission is to develop and commercialize the world’s first oral vaccine for avian influenza, combining breakthrough science with practical delivery methods to address a $10 billion+ market.

By simplifying disease prevention for poultry producers, reducing economic losses, and mitigating zoonotic risks, we aim to deliver unparalleled value to stakeholders and ensure a sustainable, healthier future. Together with our partners and investors, we are redefining how the world protects against the threats of infectious diseases.

Social media

SUPPLY CHAIN MANAGEMENT AND LOGISTICS

Cold chain managementDistribution and logistics

CLINICAL DEVELOPMENT AND TRIALS

Infectious diseases

INVESTMENT AND BUSINESS DEVELOPMENT

Investment and funding

THERAPEUTIC AREAS

Infectious diseasesOncology

MANUFACTURING AND PRODUCTION

Vaccine manufacturing

RESEARCH AND DEVELOPMENT

Vaccine developmentVaccine delivery systemsVaccine platforms

Representatives

Perjan Pleunis

ceo

LivingMed Biotech